EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Fibromat (M) Berhad (0355) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Fibromat (M) Berhad MYR 1.23, price MYR 0.75, upside +64.0%, quality 44 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Industrials · MY

FM Thin data Sep 24, 2026

Fibromat (M) Berhad

0355 · KLSE

Cheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.

✓Fair value 1.23 MYR · Strongly undervalued (+64%)
!Quality 44/100
!Expensive Growth (revenue 3y +33.3 %/yr)
✓Solidly profitable · 13.8% net margin (TTM)
!Low debt · negative free cash flow
✓Ranks above peers (10/13)
✓Wide moat 68/100
!Insider activity 40/100
!Evidence only low, so the estimate is less certain
!The models disagree: range 0.9000 MYR to 2.50 MYR
!Weak on dividend: 23 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

0.9150 MYR 0.2626 MYR Fair Value 1.23 MYR May 2019 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 0.2626 MYR – 0.9150 MYR · fair‑value band 0.9000 MYR – 2.50 MYR · the 0.7500 MYR price screens below the 1.23 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Fibromat (M) Berhad in your weekly email

Every Wednesday you see whether Fibromat (M) Berhad is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Fibromat (M) Berhad, an investment holding company, engages in geotechnical solutions for erosion control, ground improvement, sediment control, and filtration and containment lining in Malaysia. It operates through three segments: Design and Installation Services, Trading, and Manufacturing.

Show more

Fibromat (M) Berhad, an investment holding company, engages in geotechnical solutions for erosion control, ground improvement, sediment control, and filtration and containment lining in Malaysia. It operates through three segments: Design and Installation Services, Trading, and Manufacturing. It provides geotechnical solutions that include designing, manufacturing, and installation of geotechnical solutions using geosynthetics, erosion control, and biomass products; engineering techniques for drainage, filtration, separation, protection, and reinforcement; and erosion control blankets. The company is also involved in the trading of geosynthetics and erosion control products; design and build services for erosion control and protection application; design, supply, and on-site installations: and manufacturing and sale of in-house products. Its products are used in various applications, including slope stabilisation, ground improvement, riverbank and coastal protection, and soil erosion control. The company was founded in 1999 and is based in Batu Caves, Malaysia.

Stock analysis

Fibromat (M) Berhad (0355) currently trades at 0.7500 MYR, while our model-based Fair Value estimate is 1.23 MYR, implying the stock looks roughly 39.0% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 3.07 MYR per share, and 9 of the 17 models we run sit above the 0.7500 MYR price.

Bear case: the Dividend Discount group reads lowest at 0.1300 MYR, and 8 of the 17 models stay below the price. Evidence for this calculation is low.

Scenario range: 0.9000 MYR (bear) to 2.50 MYR (bull), the price of 0.7500 MYR sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 44/100 (below-average quality), in the Industrials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Fibromat (M) Berhad reported revenue of 113M MYR in FY2025 versus 45.8M MYR in FY2021, a compound +25.5%/yr. Reported net income was 16.4M MYR in FY2025, compounding +29.9%/yr from FY2021.

Key figures

Market cap 186M MYR (≈ $45.7M) · P/E ratio 9.4 · P/S ratio 1.35 · EPS (TTM) 0.0800 MYR · Dividend yield 1.1% · Net margin 14.4% · Return on equity 21.5% · Return on assets (EBIT) 14.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).

What moves the price

The share trades about 18% below its 52-week high and 18% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −28% fair-value upside, at 64%, 0355 screens cheaper than that median.

Fair Value models

Bear 0.9000 MYR Fair Value 1.23 MYR Bull 2.50 MYR
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.0587 MYR per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
EPV 0.6400 MYR 0.7500 MYR 0.8400 MYR 71
EV/EBITDA 0.9300 MYR 1.25 MYR 1.57 MYR 67
ROIC Compounder 0.8800 MYR 1.37 MYR 1.67 MYR 67
All 17 models by family
DCF Models
Owner Earnings 0.0600 MYR 0.1800 MYR 0.4300 MYR 63
Earnings-Based
Graham-Dodd 0.4500 MYR 3.13 MYR 4.39 MYR 59
Lynch FV 1.62 MYR 2.31 MYR 3.00 MYR 57
PEG = 1.0 1.62 MYR 2.31 MYR 3.00 MYR 53
EPV 0.6400 MYR 0.7500 MYR 0.8400 MYR 71
Dividend Discount
Gordon GGM 0.0800 MYR 0.1500 MYR 0.2300 MYR 62
DDM Multi-Stage 0.0800 MYR 0.1300 MYR 0.1600 MYR 62
Multiples
P/E Multiple 1.09 MYR 1.45 MYR 1.82 MYR 63
P/S Multiple 0.4100 MYR 0.5500 MYR 0.6900 MYR 58
P/B Multiple 0.8400 MYR 1.12 MYR 1.40 MYR 55
EV/EBIT 1.24 MYR 1.67 MYR 2.10 MYR 66
EV/EBITDA 0.9300 MYR 1.25 MYR 1.57 MYR 67
EV/Revenue 0.3400 MYR 0.5100 MYR 0.6700 MYR 53
Asset-Based
NCAV (Graham) 0.1800 MYR 0.2400 MYR 0.3500 MYR 54
Economic Profit
Residual Income 0.4300 MYR 0.5900 MYR 2.60 MYR 59
ROIC Compounder 0.8800 MYR 1.37 MYR 1.67 MYR 67
Growth Earnings
Growth-Adj P/E 2.15 MYR 3.07 MYR 3.99 MYR 63

Open the full fair value analysis →

Notify me when 0355 reaches fair value

Put 0355 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 44/100

Of which business quality 44 · Market factors (momentum, volatility) 49

Profitability 60
Margins and returns on capital today
Quality Growth 54
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 80
Balance sheet, leverage, solvency risk
Investment 6
Disciplined investing over empire-building
Low Volatility 66
Calm price path (market factor)
Momentum 40
Price trend over the last 3–12 months (market factor)
52W Momentum 43
Distance to the 52-week high (market factor)
Net Issuance 57
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+50.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+33.3%
What shareholders gained per year (last 5 years), in MYR (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in MYR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+28.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year+27.5%
Dividend (yield on the price)1.1%
Profit margin 2021 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 21%
2025 sits 68% above its own trend. The rate follows the median trend of the last 5 years, not that single year.

Watch 0355, get fair value alerts →

Compare Fibromat (M) Berhad with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pollution & Treatment Controls · 94 stocks

Beats the industry median on 10/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 44 · Below median
Fair Value upside +60% · Top 25%
Profitability
Return on equity (TTM) 21% · Top 25%
Return on assets 13% · Top 25%
Net margin (TTM) 14% · Top 25%
Operating margin (TTM) 18% · Top 25%
Growth and dividend
Revenue growth 33% · Top 25%
Dividend yield (TTM) 1.1% · Below median
Balance sheet
Debt / equity 0.21× · Above median

Valuation Multiplesvs Pollution & Treatment Controls median · lower = cheaper

P/E (TTM) 9.4× · Cheapest 25%
P/B 0.53× · Cheapest 25%
P/S (TTM) 0.35× · Cheapest 25%
EV/EBITDA 1.8× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 2
FUTURE (revenue growth)100 · sector 11
PAST (return on equity)86 · sector 18
HEALTH (low debt)90 · sector 94
DIVIDEND (yield)23 · sector 37

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Pollution & Treatment Controls stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Veralto Corporation VLTO $95.79 $69.11 −28%
Zurn Elkay Water Solutions Corporation ZWS $46.91 $49.84 +6%
Canmax Technologies Co 300390 ¥54.23 ¥10.07 −81%
CECO Environmental Corp CECO $73.71 $15.27 −79%
Fujian Longking Co 600388 ¥17.22 ¥15.59 −9%
Munters Group MTRS kr 136.05 kr 48.58 −64%
China Conch Venture Holdings 0586 HK$7.59 HK$14.40 +90%
Mega Union Technology Inc 6944 760.00 TWD 836.00 TWD +10%
Hebei Sailhero Environmental Protection High-tech Co 300137 ¥11.49 ¥2.24 −81%
MayAir Technology (China) Co 688376 ¥65.14 ¥18.80 −71%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Fibromat (M) Berhad Fair Value". https://www.fairvalue-calculator.com/stock/0355

Frequently asked questions

Is Fibromat (M) Berhad (0355) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 1.23 MYR versus a price of 0.7500 MYR, about +64% upside (undervalued).
What is the fair value of 0355?
Our model-based fair value for Fibromat (M) Berhad is 1.23 MYR (as of Sep 24, 2026), built from audited fundamentals. The current price: 0.7500 MYR.
What is the quality score of 0355?
Fibromat (M) Berhad has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Fibromat (M) Berhad (0355)?
Our model-based price target is the fair value of 1.23 MYR (as of Sep 24, 2026) from 17 valuation models. Cautious scenario 0.9000 MYR, optimistic scenario 2.50 MYR. It is a calculation from audited fundamentals, not an analyst target.
What is the Fibromat (M) Berhad stock forecast for 2026?
Our models put fair value at 1.23 MYR, about +64% upside versus a price of 0.7500 MYR (undervalued). Cautious scenario 0.9000 MYR, optimistic scenario 2.50 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of Fibromat (M) Berhad (0355)?
Fibromat (M) Berhad reported trailing-twelve-month revenue of about 135M MYR (latest available figure, as of Sep 24, 2026).
Does Fibromat (M) Berhad pay a dividend?
Fibromat (M) Berhad currently shows a dividend yield of about 1.13% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Fibromat (M) Berhad (0355)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Fibromat (M) Berhad it is 1.23 MYR per share (as of Sep 24, 2026), against a price of 0.7500 MYR. It is the blended result of 17 valuation models (cash flow, earnings, asset, dividend).
Is Fibromat (M) Berhad stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 0355 trades below its calculated fair value: price 0.7500 MYR, fair value 1.23 MYR, a gap of about +64% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0355?
No. The price is what the market pays today (0.7500 MYR); the fair value is what the company's own numbers justify (1.23 MYR). For Fibromat (M) Berhad the two are 0.4800 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is Fibromat (M) Berhad worth?
The market values Fibromat (M) Berhad at about 186M MYR (market capitalisation, as of Sep 24, 2026). Per share that is 0.7500 MYR; our models calculate a fair value of 1.23 MYR per share.
What do the bullish and bearish scenarios say about 0355?
Our models span a range for Fibromat (M) Berhad: cautious scenario 0.9000 MYR, base 1.23 MYR, optimistic 2.50 MYR per share (as of Sep 24, 2026, price 0.7500 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 0355?
Fibromat (M) Berhad trades at a price-to-earnings ratio of 9.4 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 1.23 MYR is built from several models across several years. Other multiples: P/B 0.5, P/S 0.3, EV/EBITDA 1.8.
How solid is the balance sheet of Fibromat (M) Berhad (0355)?
Balance-sheet figures for Fibromat (M) Berhad (as of Sep 24, 2026): return on equity 21.5%, debt of 0.21 per unit of equity. They feed the Quality Score of 44/100, which measures business quality independently of the share price.
How far is 0355 from its 52-week high?
Fibromat (M) Berhad trades at 0.7500 MYR, about 18% below its 52-week high of 0.9150 MYR and 18% above the low of 0.6350 MYR (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 1.23 MYR is for.
Which stocks are comparable to Fibromat (M) Berhad?
From the same area (Industrials) we also value Veralto Corporation, Zurn Elkay Water Solutions Corporation, Canmax Technologies Co, CECO Environmental Corp, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Fibromat (M) Berhad stock attractive at the current price?
The data as of Sep 24, 2026: price 0.7500 MYR, calculated fair value 1.23 MYR (+64%), Quality Score 44/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0355 calculated?
We run Fibromat (M) Berhad through 17 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 1.23 MYR, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Fibromat (M) Berhad currently trades 64 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Fibromat (M) Berhad (0355)?
The closing price on Sep 24, 2026 was 0.7500 MYR. Our model-based fair value is 1.23 MYR, about +64% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Fibromat (M) Berhad right now?
The large discount to fair value meets weak quality (44/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (0.9000 MYR). The market is more pessimistic than our downside scenario. The model range is unusually wide (0.9000 MYR to 2.50 MYR). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Fibromat (M) Berhad

How large is the market capitalisation of Fibromat (M) Berhad (0355)?
The market capitalisation of Fibromat (M) Berhad is 186M MYR (≈ $45.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Fibromat (M) Berhad (0355)?
The price-to-sales ratio of Fibromat (M) Berhad is 1.35 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Fibromat (M) Berhad (0355)?
Earnings per share at Fibromat (M) Berhad are 0.0800 MYR (price ÷ EPS = P/E 9.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Fibromat (M) Berhad (0355)?
The dividend yield of Fibromat (M) Berhad is 1.1% (payout 10.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Fibromat (M) Berhad (0355)?
The net margin of Fibromat (M) Berhad is 14.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Fibromat (M) Berhad (0355)?
The return on equity (ROE) of Fibromat (M) Berhad is 21.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Fibromat (M) Berhad (0355)?
On an EBIT basis the return on assets of Fibromat (M) Berhad is 14.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Fibromat (M) Berhad (0355)?
The operating margin of Fibromat (M) Berhad is 18.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Fibromat (M) Berhad (0355)?
Revenue at Fibromat (M) Berhad is growing +32.6% versus a year earlier (3y avg +33.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Fibromat (M) Berhad (0355)?
Earnings per share at Fibromat (M) Berhad are growing −3.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Fibromat (M) Berhad (0355) generate?
The free cash flow of Fibromat (M) Berhad is −26.9M MYR (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Fibromat (M) Berhad (0355) carry?
The net debt of Fibromat (M) Berhad is 15.7M MYR (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Fibromat (M) Berhad in the live analysis

One click puts Fibromat (M) Berhad on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.